Our in vitro final results advise that EAM-2201 should be examined when it comes to prospective in vivo pharmacokinetic drug–drug interactions because of time-dependent inhibition of CYP2C8, CYP2C9, CYP2C19 and CYP3A4 activities and competitive inhibition of UGT1A3 activity. By means of extended use, this sort of drug is able of https://actorh050mod7.wikimeglio.com/user